Skip to main content Accessibility help
×
Home

P-1096 - Integration of Clinical, Psychosocial, Cognitive and Genetic Measures to Predict Antidepressant Treatment Outcome in mdd Patients: a Preliminary Clinical Study

  • K. Lin (a1) (a2), G. Xu (a1) (a2), Y. Guo (a1) (a2), D. Rao (a1) (a2), H. Ouyang (a1) (a2), Y. Dang (a1) (a2), M. Zhang (a1) (a2), Y. Jia (a1) (a2) and C. Ma (a1) (a2)...

Abstract

Objectives

The main aim of this study is to investigate the capacity of a number of variables from four dimensions (clinical, psychosocial, cognitive and genetic domains) to predict the antidepressant treatment outcome, and combined the predictors in one integrate regression model with the aim to investigate which predictor contributed most.

Methods

In a semi-naturalistic prospective cohort study with a total of 241 fully assessed MDD patients, decrease in HAM-D scores from baseline to after 6 weeks of treatment was used to measure the antidepressant treatment outcome.

Results

The clinical and psychosocial model (R2 = 0.451) showed that HAM-D scores at baseline and MMPI-2 scale paranoia was the best clinical and psychosocial predictor of treatment outcome respectively. The cognitive model (R2 = 0.502) revealed that combination of better performance on TMT-B test and worse performance on TOH and WAIS-R Digit Backward testes could predict decline in HAM-D scores. The genetics analysis only found median of percent improvement in HAM-D scores in G-allele of GR gene BclI polymorphism carriers (72.2%) was significant lower than that in non-G allele carriers (80.1%). The integrate model showed that three predictors, combination of HAM-D scores at baseline, MMPI-2 scale paranoia and TMT-B test, explained 57.1% of the variance.

Conclusion

Three markers, HAM-D scores at baseline, MMPI-2 scale paranoia and TMT-B test, might serve as predictor of antidepressant outcome in daily psychiatric practice.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      P-1096 - Integration of Clinical, Psychosocial, Cognitive and Genetic Measures to Predict Antidepressant Treatment Outcome in mdd Patients: a Preliminary Clinical Study
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      P-1096 - Integration of Clinical, Psychosocial, Cognitive and Genetic Measures to Predict Antidepressant Treatment Outcome in mdd Patients: a Preliminary Clinical Study
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      P-1096 - Integration of Clinical, Psychosocial, Cognitive and Genetic Measures to Predict Antidepressant Treatment Outcome in mdd Patients: a Preliminary Clinical Study
      Available formats
      ×

Copyright

P-1096 - Integration of Clinical, Psychosocial, Cognitive and Genetic Measures to Predict Antidepressant Treatment Outcome in mdd Patients: a Preliminary Clinical Study

  • K. Lin (a1) (a2), G. Xu (a1) (a2), Y. Guo (a1) (a2), D. Rao (a1) (a2), H. Ouyang (a1) (a2), Y. Dang (a1) (a2), M. Zhang (a1) (a2), Y. Jia (a1) (a2) and C. Ma (a1) (a2)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

P-1096 - Integration of Clinical, Psychosocial, Cognitive and Genetic Measures to Predict Antidepressant Treatment Outcome in mdd Patients: a Preliminary Clinical Study

  • K. Lin (a1) (a2), G. Xu (a1) (a2), Y. Guo (a1) (a2), D. Rao (a1) (a2), H. Ouyang (a1) (a2), Y. Dang (a1) (a2), M. Zhang (a1) (a2), Y. Jia (a1) (a2) and C. Ma (a1) (a2)...
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *